Company

About

AbCheck

AbCheck

Plzen, Czech Republic

AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, AbCheck leverages both cutting-edge (e.g., microfluidics, rabbit mass humanization) and state-of-the-art (e.g., phage/yeast display libraries) technologies to provide high quality leads. The company has proven its capabilities in multiple partnerships throughout the U.S. and Europe. AbCheck is a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company.

Bioinova

Bioinova

Prague

Production of therapeutically acting cell lines (somatocellular therapy) under the GMP regulations, FDF - final dosage forms, project management and development in GMP. Currently running and/or preparing multiple clinical trials with mesenchymal stem cells. Contractual manufacturing GMP. Czech biotechnology company primarily dedicated to research and development of novel stem cell-based therapies

SOTIO Biotech

SOTIO Biotech

Prague, Czech Republic

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

Synthon

Synthon

Blansko, Czech Republic

Synthon is an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic medicines for patients around the world. Synthon's innovative R&D and proven ability to manufacture and distribute high-quality pharmaceuticals position the company well for the future. We work to develop therapies that address the needs of people worldwide and help improve their health and well-being. Through the provision of high-quality generic medicines, we make treatments more affordable and increase access to important remedies. Currently, our products are approved by regulatory agencies in more than 90 countries and marketed through strategic partnerships and – in dedicated areas – through direct sales. Synthon’s head office is based in Nijmegen, the Netherlands, and the company has affiliates in eight other countries. Synthon employs around 1,600 staff worldwide. In 2019, the company recorded a turnover of EUR 261 million. We are interested in result-oriented people with a sharp mind and entrepreneurial spirit, who can contribute to our ambition to provide solutions to the healthcare challenges of today and tomorrow. Interested in a new step in your pharma career? We would like to get to know you! For more information, go to www.synthon.com. In case your comment to one of our posts is missing, please check out our guidelines on www.synthon.com/information/comment-missing.